Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001104659-23-008604

Options or other derivatives

  • Director acquired 2,859 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Walts Alan Edmund · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-01-30 Grant or award : show line 1 in the form Stock Options (Right to Buy) +2,859 2,859 D
Loading xslF345X03/tm234943-4_4seq1.xml…